2023 World Conference on Lung Cancer (Posters)-EP07.01. Development of a Shared Decision-Making Tool for Adjuvant Treatment for Patients with Resected Non-Small Cell Lung Cancer.

EP07.01. Development of a Shared Decision-Making Tool for Adjuvant Treatment for Patients with Resected Non-Small Cell Lung Cancer. - PDF(Abstract)

Back to course

Pdf Summary

The development of a shared decision-making tool for adjuvant treatment in patients with resected non-small cell lung cancer (NSCLC) was presented at the WCLC 2023 conference. The tool, called NSCLC Adjuvant Choice, aims to assist physicians in offering personalized treatment options by providing tailored estimates of the potential benefits, harms, and practical inconveniences of available treatments. A multidisciplinary team of clinicians, SDM researchers, and design experts implemented a human-centered design approach to develop the tool. They reviewed the current evidence and observed usual practice to inform the prototype development. The tool includes a calculator of the patient's risk of dying within 5 years, depicted in a 100-person pictograph, to show the approximate proportion of patients who will and will not die with different treatment options. Data entry, such as PDL11%, EGFR mutation, and TNM staging, is required to generate the risk calculation. The tool also supports discussion of treatment requirements, side effects, and special considerations for each option. During field testing, the tool was easily adopted by providers and patients. The use of shared decision-making facilitates communication between patients and clinicians to make informed treatment decisions that align with patients' preferences. The decision aid supports discussions on systemic therapy options, survival risk approximation, potential harms, and practical considerations. Making timely decisions about adjuvant therapy after NSCLC surgery is crucial for improving clinical outcomes.

Asset Subtitle

Konstantinos Leventakos

Meta Tag

Speaker Konstantinos Leventakos

Topic Early-Stage NSCLC: Best Practice

Keywords

shared decision-making tool

adjuvant treatment

non-small cell lung cancer

NSCLC

NSCLC Adjuvant Choice

personalized treatment options

benefits and harms

human-centered design

risk calculation

clinical outcomes